Status: Not yet recruiting
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
This is a Phase II clinical study for people with stage IV cancer. The study will evaluate the use of stereotactic body radiation therapy (SBRT), a type of focused radiation treatment, together with immunotherapy-based treatment. SRBT will be used to treat multiple areas of cancer that have spread to other parts of the body. The study will evaluate whether this treatment approach can be safely given while patients continue their planned cancer treatment and may help control their cancer.
Participants needed: 35
Trial details
Phase: Phase 2Age: 18-99Biological sex: AllType: InterventionalSponsor: Mark BernardUpdated: Aug 20, 2026Locations: 1
Eligibility criteria
Histologically proven advanced or stage IV head & neck, non-small cell lung canc... [+23]
Presence of < or equal to 5 sites amenable to SBRT [+10]